Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | AMX-500 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on AMX-500 (SAR446329) (Sep 2023). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| AMX-500 | AMX500|AMX 500|SAR446329|SAR-446329|SAR 446329|VIR-5500|VIR5500 | Limited information is currently available on AMX-500 (SAR446329) (Sep 2023). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05997615 | Phase I | AMX-500 AMX-500 + Darolutamide AMX-500 + Enzalutamide | Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer | Recruiting | GBR | ESP | AUS | 0 |